Completed
A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
NCT00834093
- Conditions
- Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States